Ireland· IE-PA-EU/1/16/1095/002
IDELVION 500 IU powder and solvent for solution for injection
A blood coagulation factors product containing rix-fp, registered in Ireland by CSL Behring GmbH. The same ATC class is registered in 4 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Rix-fp is registered in 4 of 19 countries.
Countries holding a registration under ATC B02BD (blood coagulation factors), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 2 of them publish a price we can compare per daily dose
Rix-fp · ATC B02BD
4 / 19 countries
- Ireland
- Italyprice
- Netherlands
- Norwayprice
The record
At a glance
HPRA (Ireland)- Active substance
- Rix-fp
- Manufacturer
- CSL Behring GmbH
- Country
- Ireland (IE)
- ATC code
- B02BD
- ATC class
- Blood coagulation factors
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/16/1095/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B02BD
Blood coagulation factors, as other registers publish it.
- ItalyAFSTYLA*1 flaconcino EV polv 1.000 Unita' Internazionali + 1 flaconcino 2,5 mlCSL BEHRING GmbH
- ItalyAFSTYLA*1 flaconcino EV polv 1.500 Unita' Internazionali + 1 flaconcino 5 mlCSL BEHRING GmbH
- ItalyAFSTYLA*1 flaconcino EV polv 2.000 Unita' Internazionali + 1 flaconcino 5 mlCSL BEHRING GmbH
- ItalyAFSTYLA*1 flaconcino EV polv 3.000 Unita' Internazionali + 1 flaconcino 5 mlCSL BEHRING GmbH
- ItalyAFSTYLA*1 flaconcino EV polv 500 Unita' Internazionali + 1 flaconcino 2,5 mlCSL BEHRING GmbH
- NetherlandsBeneFIX 1500 IE, poeder voor injectievloeistofPfizer Europe MA EEIG
- NorwayFactor X P behringCSL Behring
- IrelandHemgenix 1 x 10^13 genome copies/mL concentrate for solution for infusionCSL Behring GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b147199a-e3b1-48bd-8e0e-3aefbdec1207 GET /v1/drugs/b147199a-e3b1-48bd-8e0e-3aefbdec1207?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for solution for injection",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"B02BD"
],
"strength": null,
"pa_number": "EU/1/16/1095/002",
"substances": [
"Rix-fp"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "11/05/2016",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about rix-fp.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.